好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Contribution of Vascular Risk Factors to Dementia and Dementia Risk Prediction Varies Across Mid- to Later-Life: The Framingham Heart Study
Aging, Dementia, and Behavioral Neurology
P1 - Poster Session 1 (9:00 AM-5:00 PM)
002

To determine the most important vascular risk factors for inclusion in age-specific dementia risk scores.

The association between vascular risk factors and dementia varies with age making generalisability of dementia risk prediction rules to individuals of different ages challenging. 

Framingham Heart Study participants with available data on the Framingham Stroke Risk Profile (FSRP) at mid-life (age 55; n=4899,57% women), late-life (ages 65/70), or later-life (ages 75 or 80[n=2386,62% women) were followed for 10-year incident dementia risk from ages 65 through 80.

Age- and sex-adjusted mid-life risk factors associated with 10-year risk of dementia from age 65 included FSRP (HR 1.16, 95% CI 1.06-1.26, per 1-SD increment in log-transformed score), diabetes mellitus (DM, HR 4.31, 95% CI 1.97-9.43) and systolic blood pressure (SBP, HR 1.12, 95% CI 1.02-1.24, per 10mmHg increment); late-life risk factors included FSRP, antihypertensive use, DM (age 65 reported: HR 1.96, 95% CI 1.09-3.52), atrial fibrillation (age 65 reported: HR 2.30, 95% CI 1.00-5.27), non-stroke cardiovascular disease (nsCVD, age 65 reported: HR 1.95, 95% CI 1.24-3.07) and stroke (age 70 only: HR 3.61, 95% CI 2.21-5.92); later-life risk factors included antihypertensive use (age 80 only: HR 0.74, 95% CI 0.62-0.89), DM (age 80 reported: HR 1.40, 95% CI 1.04-1.89), atrial fibrillation (age 80 reported: HR 1.43, 95% CI 1.07-1.92) and stroke (age 80 reported: HR 1.63, 95% CI 1.13-2.35). In stepwise models, SBP and DM at age 55, nsCVD at age 65, DM and stroke at ages 70 and 75, and DM, stroke and use of antihypertensives (protective) at age 80 were the most important vascular risk factors for dementia.

Our findings support the use of age-specific dementia risk scores which should prioritise including, at age 55, SBP and DM; age 65, nsCVD; ages 70 and 75, DM and stroke; and age 80, DM, stroke and antihypertensive use.

Authors/Disclosures
Emer McGrath, MB, BCh, PhD (HRB Clinical Research Facility, University of Galway)
PRESENTER
Dr. McGrath has nothing to disclose.
Alexa Beiser Alexa Beiser has nothing to disclose.
Adrienne O'Donnell No disclosure on file
Jayandra Himali Jayandra Himali has nothing to disclose.
Matthew Pase, PhD (Monash University) Dr. Pase has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alzheimer's Disease Drug Discovery Foundation.
Claudia L. Satizabal, PhD (UT Health San Antonio) The institution of Dr. Satizabal has received research support from NIH and TARCC.
Sudha Seshadri, MD, FAAN (Glenn Biggs Institute for Alzheimer'S and Neurodegenerative Diseases) Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Seshadri has received research support from NIH. The institution of Dr. Seshadri has received research support from Alzheimer Association.